1 / 8

Smoking Cessation and Nicotine De-addiction Products Market

The revenue generated by the market was over USD 20 billion in 2022 and is expected to reach more than USD 47 billion in 2028 and is expected to grow with a CAGR of about 15% over the forecast period 2022-2028.

sonali58
Download Presentation

Smoking Cessation and Nicotine De-addiction Products Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Smoking Cessation and Nicotine De-addiction Products Market

  2. Download Sample PDF

  3. Market Drivers Growing health consciousness among cigarette smokers. Accessibility to a large range of nicotine replacement therapy (NRT) products.

  4. Market Segmentation

  5. Segmentation by Region North America • Asia Pacific • Europe • RoW • China, Japan, India, • South Korea, Australia, Rest of Asia-Pacific • Germany, United Kingdom, France, Italy, Rest of Europe Latin America, Middle East, Africa U.S., Canada, Mexico

  6. Leading Market Players • Takeda Pharmaceutical Co., Ltd. • Pfizer, Inc. • NJOY, Inc. • Imperial Tobacco Company of India Limited. • Cipla Ltd. • Revolymer PLC • Novartis International AG • Mcneil AB • Glaxo Smith Kline PLC • Others

  7. 2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Contact: Pimpri-Chinchwad, Maharashtra 411027 Call Us: +91 99239 50043  Mail: info@infiniumglobalresearch.com Web: www.infiniumglobalresearch.com

  8. Thank You!!

More Related